high risk
Showing 1 - 12 of 12
Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation
Not yet recruiting
- Prostate Cancer
- +2 more
- Apalutamide 60mg Tab
- Androgen deprivation therapy(ADT)
-
Nanjing, Jiangsu, China
- +2 more
Mar 17, 2023
Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- High Risk
-
Houston, TexasHouston Methodist
Dec 8, 2022
Elective Surgery, High Risk, Prevention of Surgical Site Infections Trial in Zürich (Whole Body and nasal decolonization with
Not yet recruiting
- Elective Surgery
- +3 more
- Whole Body and nasal decolonization with octenidin (Octenisan Set)
- Questionnaire for study participants immediately after the decolonization
-
Zürich, Zurich, SwitzerlandBalgrist University Hospital
Dec 9, 2022
Infection Cardiac, Heart Failure, Cardiac Implantable Electronic Device Infections Trial in Naples (Tauropace)
Recruiting
- Infection Cardiac
- +3 more
- Tauropace
-
Naples, ItalyProf Antonio Rapacciuolo,MD, PhD
Nov 8, 2022
Diet, Healthy, High Risk Trial (Mediteranean to Western to Mediteranean Diet, Western to Mediteranean to Western Diet)
Not yet recruiting
- Diet, Healthy
- High Risk
- Mediteranean to Western to Mediteranean Diet
- Western to Mediteranean to Western Diet
- (no location specified)
Oct 17, 2022
Asymptomatic, High Risk, Diabetes Trial in Belgrade (Echocardiography, CT angiography)
Recruiting
- Asymptomatic
- +2 more
- Echocardiography
- CT angiography
-
Belgrade, SerbiaClinical Centre of Serbia
Aug 11, 2021
Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)
Unknown status
- Myeloma
- +2 more
- bortezomib
- +2 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 15, 2020
High Risk, Pregnancy Trial in Faisal (Fetal movement count)
Completed
- High Risk
- Pregnancy
- Fetal movement count
-
Faisal, Giza, EgyptRania Mahmoud Abdel Ghani
Sep 10, 2020
Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk Trial in Canada, Germany, United States
Completed
- Autoantibody Positive
- +3 more
- Teplizumab
- Placebo infusion
-
San Francisco, California
- +18 more
Jul 21, 2020
Hodgkin Lymphoma in First Complete Remission
Completed
- Hodgkin Lymphoma
- +2 more
- Standard cohort: Clinical lab follow-up
- Imaging cohort: integrated imaging follow-up
- (no location specified)
Mar 4, 2020
High Risk, Breast Cancer, Positive Nodes Trial in New York (Doxorubicin, Cyclophosphamide, G-CSF)
Completed
- High Risk
- +4 more
- Doxorubicin
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 24, 2017
T-cell Lymphoma Adults, Previously Untreated, High Risk Trial in GuangZhou (chemo (CHOP), chemo(c-ATT))
Unknown status
- T-cell Lymphoma Adults
- +2 more
- chemotherapy (CHOP)
- chemotherapy(c-ATT)
-
GuangZhou, Guangdong, ChinaTumor center, Sun Yat-sen University
Dec 10, 2015